Benchmark study shows ConvNeXt models achieve 98.37% accuracy in Alzheimer's MRI detection, indicating potential for real-time screening.
Alzheimer's disease (AD) is a leading worldwide cause of cognitive impairment, necessitating accurate, inexpensive diagnostic tools to enable early recognition. In this study, we present a robust deep learning approach for AD classification based on structural MRI scans, ConvNeXt, an emergent convolutional architecture inspired by vision transformers,. We further present AlzaSet, a novel, expertly labeled clinical dataset with axial, coronal, and sagittal perspectives from AD and cognitively normal control subjects. Three ConvNeXt sizes (Tiny, Small, Base) were compared and benchmarked against existing state-of-the-art CNN models (VGG16, VGG19, InceptionV3, DenseNet121). ConvNeXt-Base consistently outperformed the other models on coronal slices with accuracy of 98.37% and an AUC of 0.992. Coronal views were determined to be most diagnostically informative, with emphasis on visualization of the medial temporal lobe. Moreover, comparison with recent ensemble-based techniques showed that superior performance with comparable computational efficiency. These results indicate that ConvNeXt-capable models applied to clinically curated data sets have strong potential to provide scalable, real-time AD screening in diverse settings, including both high-resource and resource-constrained settings.
No takes yet. Share an insight, caveat, or question.
Basereh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: